Announcements Trials
Browse Landscape

Phase

Phase 2 61Phase 1 52Phase 1/2 29Phase NA 15Phase 3 15Phase 2/3 5Phase EARLY_PHASE1 3Phase 4 2

Status

Completed 24Unknown 21Not yet recruiting 6Recruiting 5Terminated 2Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Trastuzumab 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Stomach Neoplasms × Clear all
NCT05354856 2024-05-02

The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.

Rigshospitalet, Denmark

Phase 4 Terminated
11 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01260194 2016-11-02

A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer

Hoffmann-La Roche

Phase 4 Terminated
4 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡